OTC Markets EXMKT - Delayed Quote USD

DMK Pharmaceuticals Corporation (DMKPQ)

0.0001
0.0000
(0.00%)
At close: May 16 at 4:00:00 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2022
12/31/2021
12/31/2020
Total Revenue
3,619.6890
4,756.0780
2,208.6800
2,776.5870
Cost of Revenue
4,969.7370
6,187.4860
6,872.1310
6,326.9710
Gross Profit
-1,350.0480
-1,431.4080
-4,663.4510
-3,550.3840
Operating Expense
17,448.9700
23,627.5580
27,405.9580
28,129.4360
Operating Income
-18,799.0180
-25,058.9660
-32,069.4090
-31,679.8200
Net Non Operating Interest Income Expense
-117.1540
44.1260
-6.6490
-4.9210
Other Income Expense
-2,239.0650
-1,182.5660
-2,523.4990
-4,159.2910
Pretax Income
-21,155.2370
-26,197.4060
-34,599.5570
-35,844.0320
Tax Provision
0.7960
2
0.7960
2.4000
Net Income Common Stockholders
-22,405.3080
-26,478.2730
-45,828.1980
-49,391.0890
Diluted NI Available to Com Stockholders
-22,405.3080
-26,478.2730
-45,828.1980
-49,391.0890
Basic EPS
-6.60
-12.60
-22.40
-44.80
Diluted EPS
-6.60
-12.60
-22.40
-44.80
Basic Average Shares
3,503.9590
2,140.7320
2,059.3880
1,108.1390
Diluted Average Shares
3,503.9590
2,140.7320
2,059.3880
1,108.1390
Total Operating Income as Reported
-25,338.6930
-25,058.9660
-32,069.4090
-36,342.4300
Total Expenses
22,418.7070
29,815.0440
34,278.0890
34,456.4070
Net Income from Continuing & Discontinued Operation
-22,232.6110
-26,478.2730
-45,828.1980
-49,391.0890
Normalized Income
-19,189.7070
-26,746.2148
-32,752.9311
-32,782.1767
Interest Income
--
44.1260
--
--
Interest Expense
379.3920
--
6.6490
4.9210
Net Interest Income
-117.1540
44.1260
-6.6490
-4.9210
EBIT
-19,880.9890
-25,058.9660
-32,069.4090
-35,839.1110
EBITDA
-19,244.9720
-23,575.4660
-30,633.6650
-33,510.0180
Reconciled Cost of Revenue
4,969.7370
6,187.4860
6,872.1310
6,326.9710
Reconciled Depreciation
636.0170
1,483.5000
1,435.7440
2,329.0930
Net Income from Continuing Operation Net Minority Interest
-21,157.2370
-26,199.4060
-34,600.3530
-35,846.4320
Total Unusual Items Excluding Goodwill
-1,967.5300
692.1630
-2,530.7150
-4,197.6100
Total Unusual Items
-1,967.5300
692.1630
-2,530.7150
-4,197.6100
Normalized EBITDA
-17,277.4420
-24,267.6290
-28,102.9500
-29,312.4080
Tax Rate for Calcs
0
0.0002
0.0003
0.0003
Tax Effect of Unusual Items
0
145.3542
-683.2931
-1,133.3547
12/31/2020 - 8/14/1995

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

RDHL RedHill Biopharma Ltd.
1.8500
+2.21%
 
KMDA Kamada Ltd.
6.94
+1.17%
 
CURLF Curaleaf Holdings, Inc.
0.8330
-0.83%
 
PTPI Petros Pharmaceuticals, Inc.
0.1331
-16.81%
 
CGC Canopy Growth Corporation
1.6600
+23.88%
 
AYTU Aytu BioPharma, Inc.
2.1300
-17.76%
 
IXHL Incannex Healthcare Inc.
0.2600
-3.17%
 
TLRY Tilray Brands, Inc.
0.4950
+12.50%